Abstract
6 out of 7 patients with severe neutropenia associated with the use of amodiaquine for malaria prophylaxis amodiaquine (400 mg weekly) plus proguanil (200 mg daily); 1 of these patients had also taken co-trimoxazole and another had taken sulphaguanidine. The 7th patient had taken amodiaquine alone, but at a higher dose. A retrospective analysis suggests that the frequency of severe neutropenia complicating amodiaquine taken prophylactically may be as high as 1 in 2000.
Original language | English (US) |
---|---|
Pages (from-to) | 411-414 |
Number of pages | 4 |
Journal | The Lancet |
Volume | 327 |
Issue number | 8478 |
DOIs | |
State | Published - Feb 22 1986 |
ASJC Scopus subject areas
- Medicine(all)